NABRIVA THERAPEUTICS PLC - SHS NEW 2022 (NBRVF)

CUSIP: G63637139

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / SHS NEW 2022
Total 13F shares
57,627
Share change
-28,824
Total reported value
$97,317
Price per share
$1.52
Number of holders
8
Value change
-$50,477
Number of buys
2
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G63637139?
CUSIP G63637139 identifies NBRVF - NABRIVA THERAPEUTICS PLC - SHS NEW 2022 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS NEW 2022 (NBRVF) as of Q2 2023

As of 30 Jun 2023, NABRIVA THERAPEUTICS PLC - SHS NEW 2022 (NBRVF) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,627 shares. The largest 8 holders included Values First Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, Activest Wealth Management, and Addison Advisors LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.